Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Option Award |
2025-04-10 1:30 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | Vasisht Niraj Director |
50,000 | $0 | 150,000 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-07 5:25 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | Yanez Michelle Director |
50,000 | $0 | 896,271 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-07 5:23 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | SEARS SAMUEL P JR Director |
50,000 | $0 | 1,279,543 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-07 5:22 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | OSMAN RONALD E Ronald E Osman Irrevocable Trust III Director 10% Owner |
50,000 | $0 | 23,554,985 (Indirect) |
View |
| 2025-04-01 Option Award |
2025-04-07 5:21 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | Jerman Michael Allen Director |
50,000 | $0 | 80,411 (Direct) |
View |
| 2024-12-02 Ownership |
2025-02-19 9:28 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | MCNULTY JAMES A Chief Financial Officer |
1,000,000 | $0 | 1,946,135 (Direct) |
View |
| 2024-12-02 Ownership |
2025-02-19 9:27 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | Yanez Michelle Director |
250,000 | $0 | 1,146,271 (Direct) |
View |
| 2024-04-01 Option Award |
2024-05-16 1:34 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | Yanez Michelle Director |
50,000 | $0 | 896,271 (Direct) |
View |
| 2024-03-16 Option Award |
2024-05-16 1:34 pm |
N/A 2034-03-16 |
Inhibitor Therapeutics Inc. | INTI | MCNULTY JAMES A CHIEF FINANCIAL OFFICER 10% Owner |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-04-01 Option Award |
2024-05-16 1:34 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | SEARS SAMUEL P JR Director |
50,000 | $0 | 1,129,543 (Direct) |
View |
| 2024-04-01 Option Award |
2024-05-16 1:34 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | OSMAN RONALD E Ronald E Osman Irrevocable Trust III Director 10% Owner |
50,000 | $0 | 23,564,985 (Indirect) |
View |
| 2024-04-01 Option Award |
2024-05-16 1:34 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | Jerman Michael Allen Director |
50,000 | $0 | 80,411 (Direct) |
View |
| 2023-08-11 Option Award |
2023-08-29 3:49 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | OSMAN RONALD E Ronald E Osman Irrevocable Trust III Director 10% Owner |
25,000 | $0 | 23,514,985 (Direct) |
View |
Ownership |
2023-08-29 2:42 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | Ronald E Osman Irrevocable Trust III OSMAN RONALD E 10% Owner |
0 | $0 | 23,489,985 (Direct) |
View |
Ownership |
2023-05-22 3:44 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | TPB 2012 LLC Donovan James Joseph III 10% Owner |
0 | $0 | 28,266,750 (Indirect) |
View |
| 2023-05-05 Other |
2023-05-17 7:46 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | MCNULTY JAMES A See Remarks 10% Owner |
100,126,261 | $0 | 127,173,453 (Indirect) |
View |
Ownership |
2023-05-17 7:10 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | Black Robe Capital LLC MCNULTY JAMES A 10% Owner |
0 | $0 | 20,101,057 (Direct) |
View |
| 2023-05-05 Other |
2023-05-17 7:09 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | Yanez Michelle Director |
796,271 | $0 | 1,596,944 (Direct) |
View |
Ownership |
2022-12-22 9:35 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | SEARS SAMUEL P JR Director |
0 | $0 | 969,096 (Direct) |
View |
Ownership |
2022-12-22 9:33 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | Yanez Michelle Director |
0 | $0 | 4,402 (Direct) |
View |
Ownership |
2022-12-22 9:33 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | ODONNELL FRANCIS E JR See Remarks 10% Owner |
0 | $0 | 85,627,069 (Indirect) |
View |
Ownership |
2022-12-22 9:31 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | MCNULTY JAMES A See Remarks 10% Owner |
0 | $0 | 86,325,069 (Direct) |
View |
| 2021-01-15 Other |
2021-01-19 1:50 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | Mayne Pharma Ventures Pty Ltd Mayne Pharma International Pty Ltd Mayne Pharma Group Ltd 10% Owner |
2,240,488 | $0 | 206,323,715 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-28 4:30 pm |
2020-12-22 2030-12-22 |
Inhibitor Therapeutics Inc. | INTI | Hasara Garrison J. CFO and Treasurer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-28 4:30 pm |
2020-12-22 2030-12-22 |
Inhibitor Therapeutics Inc. | INTI | Watson W. Mark Director |
1,306,452 | $0 | 1,306,452 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-28 4:30 pm |
2020-12-22 2030-12-22 |
Inhibitor Therapeutics Inc. | INTI | Ono Richard Dana Director |
754,839 | $0 | 754,839 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-28 4:30 pm |
2020-12-22 2030-12-22 |
Inhibitor Therapeutics Inc. | INTI | Peattie Debra Director |
580,646 | $0 | 580,646 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-28 4:30 pm |
2020-12-22 2030-12-22 |
Inhibitor Therapeutics Inc. | INTI | VIRCA NICHOLAS J President and CEO |
125,000 | $0 | 125,000 (Direct) |
View |
| 2020-12-22 Option Award |
2020-12-28 4:30 pm |
2020-12-22 2030-12-22 |
Inhibitor Therapeutics Inc. | INTI | Martin Robert Daniel Director |
754,839 | $0 | 754,839 (Direct) |
View |
| 2020-09-17 Option Award |
2020-09-21 6:42 pm |
2020-09-17 2030-09-17 |
Inhibitor Therapeutics Inc. | INTI | VIRCA NICHOLAS J President and CEO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2020-09-17 Option Award |
2020-09-21 6:39 pm |
2020-09-17 2030-09-17 |
Inhibitor Therapeutics Inc. | INTI | Hasara Garrison J. CFO and Treasurer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2020-07-15 Other |
2020-07-20 9:56 pm |
N/A N/A |
Inhibitor Therapeutics Inc. | INTI | Mayne Pharma Ventures Pty Ltd Mayne Pharma International Pty Ltd Mayne Pharma Group Ltd 10% Owner |
3,189,688 | $0 | 205,032,427 (Direct) |
View |